E3 ligase Ligand-Linker Conjugates 17|CAS 1950635-16-1|DC Chemicals

Cas No.:	1950635-16-1
Chemical Name:	E3 ligase Ligand-Linker Conjugates 17
Synonyms:	Thalidomide-O-amido-C8-NH2 TFA;Thalidomide-O-amido-C8-NH2 (TFA);N-(8-aminooctyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate;BCP32541;AT18336;A936454;N-(8-aminooctyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoiso;E3 ligase Ligand-Linker Conjugates 17
SMILES:	FC(C(=O)O[H])(F)F.O(C([H])([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])=O)C1=C([H])C([H])=C([H])C2=C1C(N(C2=O)C1([H])C(N([H])C(C([H])([H])C1([H])[H])=O)=O)=O
Formula:	C₂₅H₃₁F₃N₄O₈
M.Wt:	572.5309
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

E3 ligase Ligand-Linker Conjugates 17 is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology.

Cat. No.	Product name	Field of application
DC47877	tri-GalNAc-COOH (acetylation)	tri-GalNAc-COOH acetylation is the acetylated and modified form of tri-GalNAc-COOH. tri-GalNAc-COOH acetylation can be used for the synthesis of LYTAC.
DC46965	Tri-GalNAc-COOH	tri-GalNAc-COOH is an asialoglycoprotein receptor (ASGPR) ligand that can be used for LYsosome TArgeting Chimera (LYTAC) research.
DC22337	E3 ligase Ligand 4(TC-E3 5032)	E3 ligase Ligand 4 is a ligand of E3 ligase, used in PROTAC technology.
DC12676	VL-285	VL285 is a potent VHL ligand, degrading HaloTag7 fusion proteins.
DC20512	VHL ligand 1	PROTAC-VHL-ligand is a von Hippel–Lindau (VHL) ligand used for the proteolysis targeting chimeras (PROTACs) method, induces target protein degradation..
DC12675	E3 ligase Ligand-Linker Conjugates 17	E3 ligase Ligand-Linker Conjugates 17 is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology.
DC22335	E3 ligase Ligand 1A	E3 ligase Ligand 1A is a ligand of E3 ligase, used in PROTAC technology; E3 ligase Ligand 1A can be used in the research of cancer. (S,R,S)-AHPC-Me (VHL ligand 2) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL)